DRKS00007855招募中未知
High-intensity focused ultrasound (HIFU) for local ablative therapy of solid tumors - HIFU-SOLTUM1909
niversitätsklinik Bonn0 个研究点目标入组 200 人开始时间: 2015年3月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Age: 18 years or older, legal capacity
- •Gender: men and women
- •Patients with solid tumors (hepatocellular carcinoma, liver metastases, bile duct cancer, pancreatic cancer, uterine fibroids, peripheral bone tumors)
- •the solid tumor is sufficient detectable by ultrasound
- •tumor board decision for HIFU treatment (non-resectable tumors)
- •ECOG (Eastern Cooperative Oncology Group) <3
排除标准
- •Participation in another clinical study
- •Surgical resection is possible (decision of the interdisciplinary tumor board)
- •Patient noteligible for anesthesia
- •Patients who are unable, in the opinion of the investigator, to enter the follow-ups
- •Pregnancy
研究者
相似试验
尚未招募
不适用
HIFU for localized prostate cancerDiseases of The genitoruinary systemKCT0003781The Catholic University of Korea, Seoul St. Mary's Hospital10
进行中（未招募）
不适用
Developing a non-invasive treatment for twin-twin transfusion syndromeTwin-twin transfusion syndromeNeonatal DiseasesFetus and newborn affected by placental transfusion syndromesISRCTN33458649Imperial College London13
尚未招募
不适用
HIFU for Benign prostatic hyperplasiaDiseases of The genitoruinary systemKCT0003780The Catholic University of Korea, Seoul St. Mary's Hospital10
尚未招募
不适用
High intensity focused ultrasound (HIFU) and Eligard in patients with high risk prostate cancerC61Malignant neoplasm of prostateprostate cancerDRKS00005179niversitätsklinikum Magdeburg A.ö.R.Dekan der Medizinische FakultätProf. Dr. Hermann-Josef-Rothkötter60
已完成
2 期
Extra-corporeal High Intensity Focused UltraSound for primary Sacrococcygeal bone TumoursPrimary osseous malignant bone tumours of the sacrococcygeal spine such as chordoma, osteosarcoma, etc.CancerISRCTN91527768Oxford University Hospitals NHS trust (UK)20